Zota Health Care Limited has acquired 10,00,000 equity shares of its wholly-owned subsidiary, Curexis Ventures Private Limited, for ₹2 crore through a subscription to a rights issue. The transaction, completed on June 22, 2026, was executed at a price of ₹20 per share, including a premium of ₹10 per share. This strategic investment is intended to support the expansion of SKIA retail pharmacy stores and address the working capital requirements of Curexis.

The acquisition does not constitute a related party transaction and was conducted on an arm's length basis, with no interest held by the promoter or group companies in Curexis. Following this investment, Curexis continues to remain a wholly-owned subsidiary of Zota Health Care Limited . No specific governmental or regulatory approvals were required for the completion of this transaction.

Curexis Ventures Private Limited operates in the pharmaceutical industry and is engaged in drug manufacturing, development, and marketing. The entity runs retail pharmacy stores under the brand name "SKIA", offering a range of pharmaceutical, nutraceutical, cosmetic, ayurvedic, and over-the-counter products. The company was incorporated on February 25, 2025, and is domiciled in India.

Financial details for Curexis indicate a turnover of ₹1.18 Lakhs for the financial year 2025-26, with a total paid-up share capital of ₹1 Lakh. The entity reported no turnover in the previous financial year, FY 2024-25, and turnover data was not available for FY 2023-24.

The following table outlines the key financial and operational details of the acquisition:

Zota Health Care Limited has acquired 20,00,000 equity shares of its wholly-owned subsidiary, KMHP Ventures Limited, for a total consideration of ₹2 Cr. The acquisition was completed on June 22, 2026, through a subscription to a rights issue at a price of ₹10 per equity share. This strategic investment is intended to support the working capital requirements of KMHP Ventures and facilitate its expansion into the retail pharmaceutical sector.

The transaction was conducted at arm's length and does not fall within the scope of related party transactions. Following this acquisition, KMHP Ventures continues to remain a wholly-owned subsidiary of Zota Health Care. No specific governmental or regulatory approvals were required for the completion of this transaction.

KMHP Ventures Limited was incorporated on January 13, 2026, and operates within the pharmaceutical industry. The subsidiary is planning to establish a chain of retail stores under the brand name "Ugo Generic". This venture will operate on both a Business to Business (B2B) and Business to Consumer (B2C) model, aiming to provide high-quality generic medicines on a PAN India basis through owned stores and approximately 12.5 lakh retail pharmacies.

According to the audited financial statements for the Financial Year 2025-26, KMHP Ventures reported a turnover of ₹NIL and a total paid-up share capital of ₹10 Lakhs. The entity had no turnover in the preceding financial years, FY 2024-25 and FY 2023-24, as it was a recently incorporated entity.

Financial Details of KMHP Ventures Limited